Artivion (AORT) Liabilities from Discontinued Operations (2021)
Artivion's (AORT) quarterly Liabilities from Discontinued Operations came in at 120000.0 in Q2 2021.
Artivion (AORT) Liabilities from Discontinued Operations (2021) Analysis & Trends
Artivion (AORT) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 120000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Artivion | 1.36 Bn | 1.29 Bn | 80.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 120,000.00 |
| Jun 30, 2021 | 120,000.00 |